Immunotherapy of HPV-associated head and neck cancer: critical parameters - HAL Accéder directement au contenu
Article dans une revue OncoImmunology Année : 2013

Immunotherapy of HPV-associated head and neck cancer: critical parameters

Résumé

Various arguments support the development of a vaccine targeting human papillomavirus (HPV) for the treatment of HPV-associated head and neck cancer. However, the mucosal localization of this tumor, the HPV-driven downregulation of MHC Class I molecules and various other immunosuppressive mechanisms must be carefully considered to improve the clinical efficacy of such an immunotherapeutic strategy.
Loading...

Dates et versions

halshs-01457167, version 1 (06-02-2017)

Identifiants

Citer

Mevyn Nizard, Federico Sandoval, Cécile Badoual, Hélène Péré, Magali Terme, et al.. Immunotherapy of HPV-associated head and neck cancer: critical parameters . OncoImmunology, 2013, 2 (6), pp.e24534. ⟨10.4161/onci.24534⟩. ⟨halshs-01457167⟩
117 Consultations
0 Téléchargements
Dernière date de mise à jour le 28/04/2024
comment ces indicateurs sont-ils produits

Altmetric

Partager

Gmail Facebook Twitter LinkedIn Plus